Literature DB >> 31576313

Role of stereotactic body radiation therapy for the management of renal cell carcinoma: tailoring treatment in the era of the "embarrassment of riches".

Sebastiano Buti1, Alessandro Leonetti1, Elisabetta Lattanzi2, Nunziata D'Abbiero2, Melissa Bersanelli1,3.   

Abstract

Entities:  

Year:  2019        PMID： 31576313      PMCID： PMC6685901          DOI： 10.21037/atm.2019.05.04

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  23 in total

1.  Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.

Authors:  Brian I Rini; Elizabeth R Plimack; Viktor Stus; Rustem Gafanov; Robert Hawkins; Dmitry Nosov; Frédéric Pouliot; Boris Alekseev; Denis Soulières; Bohuslav Melichar; Ihor Vynnychenko; Anna Kryzhanivska; Igor Bondarenko; Sergio J Azevedo; Delphine Borchiellini; Cezary Szczylik; Maurice Markus; Raymond S McDermott; Jens Bedke; Sophie Tartas; Yen-Hwa Chang; Satoshi Tamada; Qiong Shou; Rodolfo F Perini; Mei Chen; Michael B Atkins; Thomas Powles
Journal:  N Engl J Med       Date:  2019-02-16       Impact factor: 91.245

Review 2.  Combining radiotherapy and cancer immunotherapy: a paradigm shift.

Authors:  Silvia C Formenti; Sandra Demaria
Journal:  J Natl Cancer Inst       Date:  2013-01-04       Impact factor: 13.506

3.  Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma.

Authors:  Ciro Franzese; Davide Franceschini; Lucia Di Brina; Giuseppe Roberto D'Agostino; Pierina Navarria; Tiziana Comito; Pietro Mancosu; Stefano Tomatis; Marta Scorsetti
Journal:  J Urol       Date:  2019-01       Impact factor: 7.450

4.  Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.

Authors:  Robert J Motzer; Nizar M Tannir; David F McDermott; Osvaldo Arén Frontera; Bohuslav Melichar; Toni K Choueiri; Elizabeth R Plimack; Philippe Barthélémy; Camillo Porta; Saby George; Thomas Powles; Frede Donskov; Victoria Neiman; Christian K Kollmannsberger; Pamela Salman; Howard Gurney; Robert Hawkins; Alain Ravaud; Marc-Oliver Grimm; Sergio Bracarda; Carlos H Barrios; Yoshihiko Tomita; Daniel Castellano; Brian I Rini; Allen C Chen; Sabeen Mekan; M Brent McHenry; Megan Wind-Rotolo; Justin Doan; Padmanee Sharma; Hans J Hammers; Bernard Escudier
Journal:  N Engl J Med       Date:  2018-03-21       Impact factor: 91.245

5.  Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma.

Authors:  Peter J Wersäll; Henric Blomgren; Ingmar Lax; Karl-Mikael Kälkner; Christina Linder; Göran Lundell; Bo Nilsson; Sten Nilsson; Ingemar Näslund; Pavel Pisa; Christer Svedman
Journal:  Radiother Oncol       Date:  2005-06-20       Impact factor: 6.280

6.  Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma.

Authors:  Mark C Ranck; Daniel W Golden; Kimberly S Corbin; Michael D Hasselle; Stanley L Liauw; Walter M Stadler; Olwen M Hahn; Ralph R Weichselbaum; Joseph Kamel Salama
Journal:  Am J Clin Oncol       Date:  2013-12       Impact factor: 2.339

7.  Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases: final report of a prospective clinical trial.

Authors:  Johnny Kao; Chien-Ting Chen; Charles C L Tong; Stuart H Packer; Myron Schwartz; Shu-Hsia Chen; Max W Sung
Journal:  Target Oncol       Date:  2013-05-10       Impact factor: 4.493

8.  Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma-a multicenter analysis of the German working group "Stereotactic Radiotherapy".

Authors:  Juliane Hoerner-Rieber; Marciana Duma; Oliver Blanck; Guido Hildebrandt; Andrea Wittig; Fabian Lohaus; Michael Flentje; Frederick Mantel; Robert Krempien; Michael J Eble; Klaus Henning Kahl; Judit Boda-Heggemann; Stefan Rieken; Matthias Guckenberger
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

9.  The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT).

Authors:  Bs Teh; C Bloch; M Galli-Guevara; L Doh; S Richardson; S Chiang; P Yeh; M Gonzalez; W Lunn; R Marco; J Jac; Ac Paulino; Hh Lu; Eb Butler; Rj Amato
Journal:  Biomed Imaging Interv J       Date:  2007-01-01

10.  Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT).

Authors:  Basel Altoos; Arya Amini; Muthanna Yacoub; Maria T Bourlon; Elizabeth E Kessler; Thomas W Flaig; Christine M Fisher; Brian D Kavanagh; Elaine T Lam; Sana D Karam
Journal:  Radiat Oncol       Date:  2015-10-28       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.